BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 29194430)

  • 1. Human Cytomegalovirus Encoded miR-US25-1-5p Attenuates CD147/EMMPRIN-Mediated Early Antiviral Response.
    Chen J; Xia S; Yang X; Chen H; Li F; Liu F; Chen Z
    Viruses; 2017 Dec; 9(12):. PubMed ID: 29194430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Cytomegalovirus MicroRNAs miR-US5-1 and miR-UL112-3p Block Proinflammatory Cytokine Production in Response to NF-κB-Activating Factors through Direct Downregulation of IKKα and IKKβ.
    Hancock MH; Hook LM; Mitchell J; Nelson JA
    mBio; 2017 Mar; 8(2):. PubMed ID: 28270578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human cytomegalovirus microRNA miR-US25-1-5p inhibits viral replication by targeting multiple cellular genes during infection.
    Jiang S; Qi Y; He R; Huang Y; Liu Z; Ma Y; Guo X; Shao Y; Sun Z; Ruan Q
    Gene; 2015 Oct; 570(1):108-14. PubMed ID: 26055091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Cytomegalovirus miR-US33as-5p Targets IFNAR1 to Achieve Immune Evasion During Both Lytic and Latent Infection.
    Zhang Q; Song X; Ma P; Lv L; Zhang Y; Deng J; Zhang Y
    Front Immunol; 2021; 12():628364. PubMed ID: 33746965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human Cytomegalovirus DNA Polymerase Subunit UL44 Antagonizes Antiviral Immune Responses by Suppressing IRF3- and NF-κB-Mediated Transcription.
    Fu YZ; Su S; Zou HM; Guo Y; Wang SY; Li S; Luo MH; Wang YY
    J Virol; 2019 Jun; 93(11):. PubMed ID: 30867312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. U
    Goodwin CM; Schafer X; Munger J
    J Virol; 2019 Dec; 93(23):. PubMed ID: 31534044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Over-expression of human cytomegalovirus miR-US25-2-3p downregulates eIF4A1 and inhibits HCMV replication.
    Qi M; Qi Y; Ma Y; He R; Ji Y; Sun Z; Ruan Q
    FEBS Lett; 2013 Jul; 587(14):2266-71. PubMed ID: 23747307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human cytomegalovirus microRNAs are carried by virions and dense bodies and are delivered to target cells.
    Mohammad AA; Costa H; Landázuri N; Lui WO; Hultenby K; Rahbar A; Yaiw KC; Söderberg-Nauclér C
    J Gen Virol; 2017 May; 98(5):1058-1072. PubMed ID: 28589873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human cytomegalovirus latent infection alters the expression of cellular and viral microRNA.
    Fu M; Gao Y; Zhou Q; Zhang Q; Peng Y; Tian K; Wang J; Zheng X
    Gene; 2014 Feb; 536(2):272-8. PubMed ID: 24361963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levels of human cytomegalovirus miR-US25-1-5p and miR-UL112-3p in serum extracellular vesicles from infants with HCMV active infection are significantly correlated with liver damage.
    Zhang J; Huang Y; Wang Q; Ma Y; Qi Y; Liu Z; Deng J; Ruan Q
    Eur J Clin Microbiol Infect Dis; 2020 Mar; 39(3):471-481. PubMed ID: 31749099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. microRNA-221 restricts human cytomegalovirus replication via promoting type I IFN production by targeting SOCS1/NF-κB pathway.
    Yan B; Ma H; Jiang S; Shi J; Yang Z; Zhu W; Kong C; Chen L; Yan H; Ma C
    Cell Cycle; 2019 Nov; 18(22):3072-3084. PubMed ID: 31550968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hcmv-miR-UL112 attenuates NK cell activity by inhibition type I interferon secretion.
    Huang Y; Chen D; He J; Cai J; Shen K; Liu X; Yang X; Xu L
    Immunol Lett; 2015 Feb; 163(2):151-6. PubMed ID: 25530545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA miR-21 attenuates human cytomegalovirus replication in neural cells by targeting Cdc25a.
    Fu YR; Liu XJ; Li XJ; Shen ZZ; Yang B; Wu CC; Li JF; Miao LF; Ye HQ; Qiao GH; Rayner S; Chavanas S; Davrinche C; Britt WJ; Tang Q; McVoy M; Mocarski E; Luo MH
    J Virol; 2015 Jan; 89(2):1070-82. PubMed ID: 25378484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The IκB Kinases Restrict Human Cytomegalovirus Infection.
    Goodwin CM; Munger J
    J Virol; 2019 May; 93(9):. PubMed ID: 30760575
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Li L; Luo D; Liao Y; Peng K; Zeng Y
    Front Immunol; 2020; 11():2052. PubMed ID: 33013867
    [No Abstract]   [Full Text] [Related]  

  • 16. Human Cytomegalovirus miR-US25-1 Targets the GTPase RhoA To Inhibit CD34
    Diggins NL; Crawford LB; Hancock MH; Mitchell J; Nelson JA
    mBio; 2021 Apr; 12(2):. PubMed ID: 33824207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The human cytomegalovirus UL26 protein antagonizes NF-κB activation.
    Mathers C; Schafer X; Martínez-Sobrido L; Munger J
    J Virol; 2014 Dec; 88(24):14289-300. PubMed ID: 25275128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different expression pattern of human cytomegalovirus-encoded microRNAs in circulation from virus latency to reactivation.
    Zhou W; Wang C; Ding M; Bian Y; Zhong Y; Shen H; Wang J; Zhang CY; Zhang C
    J Transl Med; 2020 Dec; 18(1):469. PubMed ID: 33298092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expression of interleukin-32 is activated by human cytomegalovirus infection and down regulated by hcmv-miR-UL112-1.
    Huang Y; Qi Y; Ma Y; He R; Ji Y; Sun Z; Ruan Q
    Virol J; 2013 Feb; 10():51. PubMed ID: 23402302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human Cytomegalovirus miR-UL112-3p Targets TLR2 and Modulates the TLR2/IRAK1/NFκB Signaling Pathway.
    Landais I; Pelton C; Streblow D; DeFilippis V; McWeeney S; Nelson JA
    PLoS Pathog; 2015 May; 11(5):e1004881. PubMed ID: 25955717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.